Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Shares Issued (2016 - 2025)

Prestige Consumer Healthcare has reported Shares Issued over the past 16 years, most recently at $752000.0 for Q3 2025.

  • Quarterly results put Shares Issued at $752000.0 for Q3 2025, down 53.49% from a year ago — trailing twelve months through Dec 2025 was $6.4 million (down 67.52% YoY), and the annual figure for FY2025 was $14.8 million, down 18.17%.
  • Shares Issued for Q3 2025 was $752000.0 at Prestige Consumer Healthcare, down from $3.2 million in the prior quarter.
  • Over the last five years, Shares Issued for PBH hit a ceiling of $8.7 million in Q4 2024 and a floor of $199000.0 in Q1 2023.
  • Median Shares Issued over the past 5 years was $2.1 million (2023), compared with a mean of $2.9 million.
  • Biggest five-year swings in Shares Issued: soared 7620.51% in 2021 and later crashed 84.95% in 2023.
  • Prestige Consumer Healthcare's Shares Issued stood at $3.0 million in 2021, then soared by 88.77% to $5.7 million in 2022, then plummeted by 71.24% to $1.6 million in 2023, then soared by 435.05% to $8.7 million in 2024, then plummeted by 91.4% to $752000.0 in 2025.
  • The last three reported values for Shares Issued were $752000.0 (Q3 2025), $3.2 million (Q2 2025), and $2.5 million (Q1 2025) per Business Quant data.